Fertility and Miscarriage Incidence After Cervical Intraepithelial Neoplasia Treatment by Thermal Ablation: A Cohort Study
Open accessAbstract
Objective: To assess the impact of thermal ablation (TA) for the treatment of cervical dysplasia on fertility and pregnancy outcomes among women screened for cervical cancer in Cameroon. Design: Retrospective cohort study. Setting: Dschang health district, Cameroon. Population: Participants aged 30–45 years from two screening trials conducted between 2015 and 2020 in Dschang District Hospital. Methods: Participants were primarily screened for human papillomavirus infection, triaged by visual inspection and treated by TA if needed. Between October 2021 and March 2022, interviews on subsequent fertility were conducted with participants treated by TA and a control group of untreated women. Main Outcome Measures: Pregnancy and miscarriage after screening/treatment. Results: A total of 760 participants (219 treated and 541 untreated) completed the survey, with a mean follow‐up time of 1297 days. Sixty‐two women (28.3%) treated by TA reported a pregnancy postscreening versus 165 (30.5%) in the control group (p = 0.550). Adjusted for potential confounders, the hazard ratio of pregnancy for treated compared with untreated women was 0.82 (0.54–1.24, p = 0.350). Among women reporting pregnancies with a known outcome and which were not voluntarily terminated, 18 (35.3%) treated participants had a miscarriage versus 31 (21.4%) in the control group (p = 0.048). In the adjusted model, no association remained between TA and miscarriage (1.04, 0.39–2.78, p = 0.935). Conclusions: In our study population, TA did not significantly impact fertility nor miscarriage risk. Our results support the widespread use of TA as a treatment of choice for precancerous cervical lesions in low‐income settings.
AI snapshot
Written from the paper’s full text.
TL;DR
In a retrospective cohort in Dschang, Cameroon, thermal ablation for cervical dysplasia was not significantly associated with subsequent pregnancy or miscarriage after adjustment. The authors conclude that their results support widespread use of thermal ablation as a treatment of choice for precancerous cervical lesions in low-income settings.
Key findings
- Among 760 participants (219 treated, 541 untreated; mean follow-up 1297 days), 28.3% of treated women reported a pregnancy postscreening versus 30.5% of untreated women (p = 0.550); adjusted hazard ratio for pregnancy was 0.82 (95% CI 0.54–1.24, p = 0.350).
- Among pregnancies with a known outcome and not voluntarily terminated, crude miscarriage was 35.3% in treated women versus 21.4% in untreated women (p = 0.048), but the adjusted association was not significant (aOR 1.04, 95% CI 0.39–2.78, p = 0.935).
- HPV-positive women had higher adjusted odds of miscarriage than HPV-negative women (aOR 2.26, 95% CI 1.15–3.58, p = 0.021).
- In a subanalysis excluding women who did not attempt pregnancy, the adjusted association with pregnancy remained nonsignificant (aHR 0.92, 95% CI 0.60–1.40, p = 0.689).
Methods
- Retrospective cohort study using participants aged 30–45 years from two cervical cancer screening trials conducted between 2015 and 2020 at Dschang District Hospital, Cameroon; follow-up interviews occurred between October 2021 and March 2022.
- Exposure was thermal ablation for HPV-positive women who were VIA/VILI positive; controls were untreated women from the source trials, including HPV-positive and HPV-negative women. Primary outcome was pregnancy since screening/treatment; secondary outcome was miscarriage.
- Analyses used chi-squared and t-tests, reverse Kaplan–Meier curves with log-rank tests, Cox regression for pregnancy, and risk ratios/logistic regression for miscarriage, with adjustment for prespecified confounders and sensitivity analyses.
Limitations
- Stated: women were included irrespective of desire for pregnancy; reproductive recommendations differed by HPV status; baseline differences existed between groups, including past infertility (22.9% treated vs 15.4% untreated); generalisability is limited to the specific West Cameroon setting; and the study lacked power for absolute fertility differences under 10% and rare obstetrical outcomes.
- Evident from the text: pregnancy, miscarriage, and desire for pregnancy were self-reported retrospectively, so recall and reporting bias are possible, and the observational design cannot exclude residual confounding.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
14 of 30 cited sources checked · 9 supported · 0 flagged · accuracy not yet measured
- Premisecitation
The effect on fertility of ablative therapies such as cryotherapy or laser vaporisation was assessed only in three studies in high-income countries.
“The effect on fertility of ablative therapies such as cryotherapy or laser vaporisation was assessed only in three studies in high‐income countries [13, 14, 15].”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [13] C. N. Spracklen, K. K. Harland, B. J. Stegmann, and A. F. Saftlas, “ Cervical Surgery for Cervical Intraepithelial Neoplasia and Prolonged Time to Conception of a Live Birth: A Case–Control Study,” BJOG: An International Journal of Obstetrics & Gynaecology 120, no. 8 (2013): 960– 965. 23489374 PMC3691952 source
- cites [14] I. Kalliala, A. Anttila, T. Dyba, T. Hakulinen, M. Halttunen, and P. Nieminen, “ Pregnancy Incidence and Outcome Among Patients With Cervical Intraepithelial Neoplasia: A Retrospective Cohort Study,” BJOG: An International Journal of Obstetrics & Gynaecology 119, no. 2 (2012): 227– 235. 21790950 source
- cites [15] L. A. Wise, S. K. Willis, R. B. Perkins, et al., “ A Prospective Study of Treatments for Cervical Intraepithelial Neoplasia and Fecundability,” American Journal of Obstetrics and Gynecology 223, no. 1 (2020): 96.e1– 96.e15. PMC8041134 31887271 source
- Premisecitation
The safety of cryotherapy on fertility and early pregnancy outcomes has been shown in older studies, albeit with low-grade quality of evidence.
“The safety of cryotherapy on fertility and early pregnancy outcomes has also been shown in older studies, albeit with low‐grade quality of evidence, contributing to its widespread use as a screen‐and‐treat approach in low‐resource settings before the advent of TA [25, 26].”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [25] WHO Guidelines: Use of Cryotherapy for Cervical Intraepithelial Neoplasia (Geneva, Switzerland: World Health Organization, 2011), WHO Guidelines Approved by the Guidelines Review Committee, http://www.ncbi.nlm.nih.gov/books/NBK138476/.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [26] R. H. Hammond and D. K. Edmonds, “ Does Treatment for Cervical Intraepithelial Neoplasia Affect Fertility and Pregnancy?,” BMJ 301, no. 6765 (1990): 1344– 1345. 2271880 PMC1664508 source
The Abstract (page unavailable) reports no adverse effect on subsequent pregnancy outcomes in two older cryosurgery series and says studies of treatment for cervical intraepithelial neoplasia found no effect on fertility. It does not specifically establish safety for early-pregnancy outcomes or grade the quality of the cryosurgery evidence as low. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Findingown data
Two hundred and twenty-seven participants reported having at least one pregnancy since screening or treatment.
“Two‐hundred and twenty‐seven participants reported having at least one pregnancy since screening or treatment.”
Quote in the paperSubstantial claim - Findingown data
When excluding women who did not attempt pregnancy, the adjusted analysis showed no significant association between thermal ablation and pregnancy (aHR 0.92 [0.60-1.40], p = 0.689).
“However, the adjusted analysis showed no significant association (aHR 0.92 [0.60–1.40], p = 0.689) (Table S3).”
Quote in the paperSubstantial claim - Findingown data
A sensitivity analysis excluding participants with missing values for BMI and HIV status did not significantly affect the results.
“To account for the high proportion of missing values for BMI and HIV status, a sensitivity analysis was conducted excluding participants with missing values, which did not significantly affect the results (Table S4).”
Quote in the paperNot a substantial claim
- Findingown data
In the adjusted model, no association remained between thermal ablation and miscarriage (1.04, 0.39-2.78, p = 0.935).
“In the adjusted model, no association remained between TA and miscarriage (1.04, 0.39–2.78, p = 0.935).”
Quote in the paperSubstantial claim - Findingown data
Among women reporting pregnancies with a known outcome and which were not voluntarily terminated, 18 (35.3%) treated participants had a miscarriage versus 31 (21.4%) in the control group (p = 0.048).
“Among women reporting pregnancies with a known outcome and which were not voluntarily terminated, 18 (35.3%) treated participants had a miscarriage versus 31 (21.4%) in the control group (p = 0.048).”
Quote in the paperSubstantial claim - Findingown data
After adjustment, HPV-positive status remained associated with higher odds of miscarriage (aOR 2.26, 95% CI 1.15-3.58, p = 0.021).
“| Positive | 54 (65.1) | 29 (34.9) | 1.97 (1.20–3.24) | 0.006 | 2.26 (1.15–3.58) d | 0.021 |”
Quote in the paperSubstantial claim- Rests on an assumption: The adjusted model including thermal ablation, age, HPV status, HIV status, BMI category, and tobacco consumption adequately controls for confounding of the association between thermal ablation and miscarriage.
- Findingown data
In crude analysis, having a gynaecological disease was associated with a higher fertility incidence compared with no gynaecological disease (HR 1.37, 95% CI 1.05-1.79, p = 0.021).
“| Yes | 90 (35.4) | 686 | 13.1 (10.7–16.1) | 1.37 (1.05–1.79) | 0.021 | 1.06 (0.80–1.41) | 0.675 |”
Quote in the paperNot a substantial claim - Findingown data
In crude analysis, parity ≥5 was associated with a lower fertility incidence compared with parity <5 (HR 0.44, 95% CI 0.33-0.59, p < 0.001).
“| ≥5 | 65 (19.2) | 1049 | 6.2 (4.9–7.9) | 0.44 (0.33–0.59) | <0.001 | 0.78 (0.57–1.08) | 0.137 |”
Quote in the paperNot a substantial claim - Findingown data
After adjustment, age 35-40 remained associated with higher odds of miscarriage (aOR 1.11, 95% CI 1.02-1.21, p = 0.019).
“| 35–40 | 31 (62.0) | 19 (38.0) | 1.10 (1.02–1.20) | 0.018 | 1.11 (1.02–1.21) | 0.019 |”
Quote in the paperNot a substantial claim- Rests on an assumption: The adjusted model including thermal ablation, age, HPV status, HIV status, BMI category, and tobacco consumption adequately controls for confounding of the association between thermal ablation and miscarriage.
- Findingown data
When excluding women who did not attempt pregnancy, the probability of pregnancy appeared slightly higher in the control group on Kaplan-Meier curves with borderline significance (p = 0.072).
“When excluding women who did not attempt pregnancy, the probability of pregnancy appeared to be slightly higher in the control group on the Kaplan–Meier curves with borderline significance (p = 0.072) (Figure S3).”
Quote in the paperNot a substantial claim - Findingown data
In crude analysis, age 35-40 was associated with a higher risk of miscarriage compared with age <35 (RR 1.10, 95% CI 1.02-1.20, p = 0.018).
“| 35–40 | 31 (62.0) | 19 (38.0) | 1.10 (1.02–1.20) | 0.018 | 1.11 (1.02–1.21) | 0.019 |”
Quote in the paperNot a substantial claim - Findingown data
After adjustment, parity ≥5 was not significantly associated with fertility incidence (aHR 0.78, 95% CI 0.57-1.08, p = 0.137).
“| ≥5 | 65 (19.2) | 1049 | 6.2 (4.9–7.9) | 0.44 (0.33–0.59) | <0.001 | 0.78 (0.57–1.08) | 0.137 |”
Quote in the paperNot a substantial claim- Rests on an assumption: The adjusted model including thermal ablation, age, HPV status, HIV status, BMI category, and tobacco consumption adequately controls for confounding of the association between thermal ablation and miscarriage.
- Findingown data
Adjusted for potential confounders, the hazard ratio of pregnancy for treated compared with untreated women was 0.82 (95% CI 0.54-1.24, p = 0.350).
“Adjusted for potential confounders, the hazard ratio of pregnancy for treated compared with untreated women was 0.82 (0.54–1.24, p = 0.350).”
- Also stated in: § Results · plain
“The adjusted hazard ratio of pregnancy for treated women was 0.82 (95% CI: 0.54–1.24, p = 0.350) (Table 2).”
Quote in the paperSubstantial claim - Also stated in: § Results · plain
- Findingown data
Follow-up duration was similar between treated, untreated HPV-positive, and untreated HPV-negative women.
“Follow‐up duration was similar between treated (mean 1273 days, SD ± 683), untreated HPV‐positive (mean 1113 ± 637) and untreated HPV‐negative (mean 1366 ± 696) women.”
Quote in the paperNot a substantial claim - Findingown data
The Kaplan-Meier curves showed no significant difference in probability of pregnancy between treatment groups (p = 0.543).
“The Kaplan–Meier curves showed no significant difference in probability of pregnancy between treatment groups (p = 0.543) (Figure 1).”
Quote in the paperSubstantial claim - Findingown data
Sixty-two women (28.3%) treated by thermal ablation reported a pregnancy postscreening versus 165 (30.5%) in the control group (p = 0.550).
“Sixty‐two women (28.3%) treated by TA reported a pregnancy postscreening versus 165 (30.5%) in the control group (p = 0.550).”
- Also stated in: § Results · plain
“Twenty‐eight per cent (n = 62) of treated women reported a pregnancy compared with 30.5% (n = 165) in the control group (p = 0.550) (Table S2).”
Quote in the paperSubstantial claim - Also stated in: § Results · plain
- Findingown data
After adjusting for potential confounders including HPV status, there was no association between treatment by thermal ablation and subsequent miscarriage (aOR 1.04, 95% CI 0.39-2.78, p = 0.935).
“After adjusting for potential confounders including HPV status, there remained no association between treatment by TA and subsequent miscarriage (aOR 1.04 [0.39–2.78], p = 0.935) (Table 3).”
- Also stated in: § Results · plain
“| Yes | 33 (64.7) | 18 (35.3) | 1.65 (1.02–2.68) | 0.048 | 1.04 (0.39–2.78) | 0.935 |”
Quote in the paperSubstantial claim- Rests on an assumption: The adjusted model including thermal ablation, age, HPV status, HIV status, BMI category, and tobacco consumption adequately controls for confounding of the association between thermal ablation and miscarriage.
- Also stated in: § Results · plain
- Findingown data
In crude analysis, the proportion of miscarriages was higher among pregnant women who had been treated with thermal ablation (35.3%) compared with the control group (21.4%, p = 0.048).
“In the crude analysis, the proportion of miscarriages was higher among pregnant women who had been treated (35.3%) compared with the control group (21.4%, p = 0.048) (Figure 2A).”
- Also stated in: § Results · plain
“| Yes | 33 (64.7) | 18 (35.3) | 1.65 (1.02–2.68) | 0.048 | 1.04 (0.39–2.78) | 0.935 |”
Quote in the paperNot a substantial claim - Also stated in: § Results · plain
- Findingown data
In crude analysis, HPV-positive status was associated with a higher risk of miscarriage compared with HPV-negative status (RR 1.97, 95% CI 1.20-3.24, p = 0.006).
“| Positive | 54 (65.1) | 29 (34.9) | 1.97 (1.20–3.24) | 0.006 | 2.26 (1.15–3.58) d | 0.021 |”
Quote in the paperNot a substantial claim - Findingown data
When stratified by HPV status, the proportion of miscarriages did not differ between HPV-positive women who had been treated and those who had not.
“However, when further stratified by HPV status, the proportion of miscarriages did not differ between HPV‐positive women treated or not (Figure 2).”
Quote in the paperSubstantial claim - Findingown data
Time to first pregnancy postscreening/treatment ranged between 0 and 65 months, with a median of 12 months (interquartile range 6-18).
“Time to first pregnancy postscreening/treatment ranged between 0 and 65 months, with a median of 12 months (interquartile range 6–18).”
Quote in the paperNot a substantial claim - Findingown data
In women screened for cervical cancer in the West Region of Cameroon, thermal ablation did not significantly impact fertility after adjusting for potential confounders (aHR 0.82 [0.54-1.24], p = 0.350).
“TA did not significantly impact fertility (aHR 0.82 [0.54–1.24], p = 0.350) or risk of miscarriage (aOR 1.04 [0.39–2.78], p = 0.935) after adjusting for potential confounders.”
- Also stated in: § Conclusion · plain
“In conclusion, treatment of suspected cervical precancerous lesions by TA did not significantly impact subsequent fertility and risk of miscarriage in a population of Cameroonian women.”
Quote in the paperSubstantial claim - Also stated in: § Conclusion · plain
- Findingown data
HPV-positive women were twice as likely to have a miscarriage than HPV-negative women.
“Interestingly, HPV‐positive women were twice as likely to have a miscarriage than HPV‐negative women.”
- Also stated in: § Conclusion · boosted
“Although this study was not designed to assess the impact of HPV infection on pregnancy outcomes, our results further indicate a strong association between HPV positivity and miscarriage rate.”
Quote in the paperSubstantial claim - Also stated in: § Conclusion · boosted
- Findingown data
In crude analysis, contraception use was associated with a higher fertility incidence compared with no contraception use (HR 1.44, 95% CI 1.09-1.91, p = 0.011).
“| Yes | 156 (33.3) | 1234 | 12.6 (10.8–14.8) | 1.44 (1.09–1.91) | 0.011 | 0.99 (0.73–1.33) | 0.945 |”
Quote in the paperNot a substantial claim - Findingown data
After adjustment, gynaecological disease was not significantly associated with fertility incidence (aHR 1.06, 95% CI 0.80-1.41, p = 0.675).
“| Yes | 90 (35.4) | 686 | 13.1 (10.7–16.1) | 1.37 (1.05–1.79) | 0.021 | 1.06 (0.80–1.41) | 0.675 |”
Quote in the paperSubstantial claim- Rests on an assumption: The adjusted model including thermal ablation, age, HPV status, HIV status, BMI category, and tobacco consumption adequately controls for confounding of the association between thermal ablation and miscarriage.
- Findingown data
In women screened for cervical cancer in the West Region of Cameroon, thermal ablation did not significantly impact risk of miscarriage after adjusting for potential confounders (aOR 1.04 [0.39-2.78], p = 0.935).
“TA did not significantly impact fertility (aHR 0.82 [0.54–1.24], p = 0.350) or risk of miscarriage (aOR 1.04 [0.39–2.78], p = 0.935) after adjusting for potential confounders.”
- Also stated in: § Conclusion · plain
“In conclusion, treatment of suspected cervical precancerous lesions by TA did not significantly impact subsequent fertility and risk of miscarriage in a population of Cameroonian women.”
Quote in the paperSubstantial claim - Also stated in: § Conclusion · plain
- Findingown data
After adjustment, contraception use was not significantly associated with fertility incidence (aHR 0.99, 95% CI 0.73-1.33, p = 0.945).
“| Yes | 156 (33.3) | 1234 | 12.6 (10.8–14.8) | 1.44 (1.09–1.91) | 0.011 | 0.99 (0.73–1.33) | 0.945 |”
Quote in the paperNot a substantial claim- Rests on an assumption: The adjusted model including thermal ablation, age, HPV status, HIV status, BMI category, and tobacco consumption adequately controls for confounding of the association between thermal ablation and miscarriage.
- Premisenone given
To date, long-term post-operative fertility and pregnancy outcomes following thermal ablation have not been evaluated in resource-constrained settings.
“To date, long‐term post‐operative fertility and pregnancy outcomes following TA have not been evaluated in resource‐constrained settings.”
Quote in the paperSubstantial claim - Premisecitation
The primary target population for cervical cancer screening in low- and middle-income countries are women aged 30-49 years with reproductive potential.
“Assessing the effect of cervical treatment on future fertility is essential in LMICs, as the primary target population for CC screening are women aged 30–49 years with reproductive potential [7].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [7] World Health Organization, WHO Guideline for Screening and Treatment of Cervical Pre‐Cancer Lesions for Cervical Cancer Prevention, 2nd ed. (Geneva, Switzerland: WHO, 2021), https://www.who.int/publications‐detail‐redirect/9789240030824. 34314129
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Study design and conductreasoning
Women were included in the analysis irrespective of their desire for pregnancy at screening, which may have confounded the association with fertility due to potentially unequal reproductive behaviours across study groups.
“First, women were included in the analysis irrespective of their desire of pregnancy at the time of screening, which may have confounded the association with fertility due to potentially unequal reproductive behaviours across study groups.”
Quote in the paperNot a substantial claim - Interpretationcitation
This study is the first to assess the effect of an ablative treatment on fertility in a low-income setting.
“Our study is also the first to assess the effect of an ablative treatment on fertility in a low‐income setting.”
Quote in the paperSubstantial claim - Interpretationreasoning
This is the first study to specifically assess the effect of thermal ablation on subsequent fertility.
“To the best of our knowledge, this is the first study to specifically assess the effect of TA on subsequent fertility.”
Quote in the paperSubstantial claim - Study design and conductown data
A sensitivity analysis considering retrospectively reported desire for pregnancy did not differ substantially from the main analysis.
“To mitigate this, a sensitivity analysis was conducted considering retrospectively reported desire for pregnancy, which did not differ substantially from the main analysis.”
Quote in the paperSubstantial claim - Interpretationown data
This is the first study to provide insight into the association between vaginal HPV infection and risk of miscarriage in a sub-Saharan African population.
“To the best of our knowledge, ours is the first study to provide insight into the association between vaginal HPV infection and risk of miscarriage in a sub‐Saharan African population.”
Quote in the paperSubstantial claim - Interpretationreasoning
Generalisability of the results cannot be assumed because the study was conducted in a specific setting in the West Region of Cameroon where population characteristics such as HPV and HIV prevalence, as well as reproductive behaviour, may impact fertility outcomes.
“Fourth, generalisability of our results cannot be assumed as the study was conducted in a specific setting in the West Region of Cameroon where population characteristics such as HPV and HIV prevalence, as well as reproductive behaviour, may impact fertility outcomes.”
Quote in the paperNot a substantial claim
- May combine two claims. 24
- Classified as probably not a substantial claim. 18
May combine two claims.
PremisecitationMost women with a positive primary HPV test are overtreated because 90% of HPV-positive women do not have high-grade cervical lesions.
“The drawback of this strategy is that most women with a positive primary HPV test are overtreated, since 90% of HPV‐positive women do not have high‐grade cervical lesions, although they could develop them in the next years [10, 11].”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [10] J. Cuzick, A. Szarewski, H. Cubie, et al., “ Management of Women Who Test Positive for High‐Risk Types of Human Papillomavirus: The HART Study,” Lancet 362, no. 9399 (2003): 1871– 1876. 14667741 source
- cites [11] C. Broquet, P. Vassilakos, F. M. Ndam Nsangou, et al., “ Utility of Extended HPV Genotyping for the Triage of Self‐Sampled HPV‐Positive Women in a Screen‐and‐Treat Strategy for Cervical Cancer Prevention in Cameroon: A Prospective Study of Diagnostic Accuracy,” BMJ Open 12, no. 12 (2022): e057234. PMC9791451 36549727 source
The Results report that 44 of 382 HPV-positive women (11.5%) had CIN2+, supporting the approximate claim that 90% did not have high-grade lesions. The Introduction says a single HPV test can lead to overtreatment, but the study used triage rather than treating every HPV-positive woman; it does not show that most HPV-positive participants were actually overtreated. The copy also does not establish whether women without lesions developed them in subsequent years. (LLM, conf=0.84)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationIn this population, adherence to treatment and screening coverage may be reduced by fear of infertility.
“In this population, adherence to treatment and screening coverage may be reduced by fear of infertility [8, 9].”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [8] C. O. Chigbu and U. U. Aniebue, “ Non‐Uptake of Colposcopy in a Resource‐Poor Setting,” International Journal of Gynecology & Obstetrics 113, no. 2 (2011): 100– 102. 21349518 source
- cites [9] N. Buchanan Lunsford, K. Ragan, J. Lee Smith, M. Saraiya, and M. Aketch, “ Environmental and Psychosocial Barriers to and Benefits of Cervical Cancer Screening in Kenya,” Oncologist 22, no. 2 (2017): 173– 181. 28167567 PMC5330703 source
The Results (page unavailable) report that some women feared speculum use during screening could cause infertility, supporting fear of infertility as a potential screening barrier. The paper does not link that fear to treatment adherence or measure its effect on screening coverage. (LLM, conf=0.86)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationThe risk of adverse effects on fertility and early pregnancy outcomes after local cervical treatment has mostly been studied for excisional therapies and did not show evidence for affected fertility.
“The risk of adverse effects on fertility and early pregnancy outcomes after local cervical treatment has mostly been studied for excisional therapies and did not show evidence for affected fertility [12].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [12] M. Kyrgiou, A. Mitra, M. Arbyn, et al., “ Fertility and Early Pregnancy Outcomes After Treatment for Cervical Intraepithelial Neoplasia: Systematic Review and Meta‐Analysis,” BMJ 349 (2014): g6192. 25352501 PMC4212006 source
May combine two claims.
PremisecitationA meta-analysis published in 2014 assessing fertility and early pregnancy outcomes after treatment of patients with suspected cervical precancerous disease identified only three studies assessing ablative methods, none of which included patients treated by thermal ablation.
“A meta‐analysis published in 2014 [12] assessing fertility and early pregnancy outcomes after treatment of patients with suspected cervical precancerous disease identified only three studies assessing ablative methods [13, 14, 23], none of which included patients treated by TA.”
Quote in the paperSubstantial claim2 of 4 sources checked- cites [12] M. Kyrgiou, A. Mitra, M. Arbyn, et al., “ Fertility and Early Pregnancy Outcomes After Treatment for Cervical Intraepithelial Neoplasia: Systematic Review and Meta‐Analysis,” BMJ 349 (2014): g6192. 25352501 PMC4212006 source
- cites [13] C. N. Spracklen, K. K. Harland, B. J. Stegmann, and A. F. Saftlas, “ Cervical Surgery for Cervical Intraepithelial Neoplasia and Prolonged Time to Conception of a Live Birth: A Case–Control Study,” BJOG: An International Journal of Obstetrics & Gynaecology 120, no. 8 (2013): 960– 965. 23489374 PMC3691952 source
- cites [14] I. Kalliala, A. Anttila, T. Dyba, T. Hakulinen, M. Halttunen, and P. Nieminen, “ Pregnancy Incidence and Outcome Among Patients With Cervical Intraepithelial Neoplasia: A Retrospective Cohort Study,” BJOG: An International Journal of Obstetrics & Gynaecology 119, no. 2 (2012): 227– 235. 21790950 source
- cites [23] M. Spitzer, J. Herman, B. A. Krumholz, and M. Lesser, “ The Fertility of Women After Cervical Laser Surgery,” Obstetrics and Gynecology 86, no. 4 Pt 1 (1995): 504– 508. 7675369 source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationLess frequent pregnancy outcomes such as preterm birth, late miscarriages, premature membrane rupture, low birthweight or ectopic pregnancy have been associated with excisional cervical treatment.
“which have been associated with excisional cervical treatment [12, 22].”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [12] M. Kyrgiou, A. Mitra, M. Arbyn, et al., “ Fertility and Early Pregnancy Outcomes After Treatment for Cervical Intraepithelial Neoplasia: Systematic Review and Meta‐Analysis,” BMJ 349 (2014): g6192. 25352501 PMC4212006 source
- cites [22] H. Zhuang, S. Hong, L. Zheng, et al., “ Effects of Cervical Conisation on Pregnancy Outcome: A Meta‐Analysis,” Journal of Obstetrics and Gynaecology 39, no. 1 (2019): 74– 81. 29884103 source
May combine two claims.
PremisecitationTwo cohort studies in North America assessed pregnancy rates following ablative treatment, showing either increased pregnancy rates for grouped ablative procedures including thermal cautery, or no significant effect for laser treatment and cryotherapy.
“More recently, two cohort studies in North America assessed pregnancy rates following ablative treatment, showing either increased pregnancy rates for grouped ablative procedures, including thermal cautery [24], or no significant effect for laser treatment and cryotherapy [15].”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [24] A. L. Naleway, S. Weinmann, G. Krishnarajah, et al., “ Pregnancy After Treatment for Cervical Cancer Precursor Lesions in a Retrospective Matched Cohort,” PLoS One 10, no. 2 (2015): e0117525. 25671561 PMC4324989 source
- cites [15] L. A. Wise, S. K. Willis, R. B. Perkins, et al., “ A Prospective Study of Treatments for Cervical Intraepithelial Neoplasia and Fecundability,” American Journal of Obstetrics and Gynecology 223, no. 1 (2020): 96.e1– 96.e15. PMC8041134 31887271 source
May combine two claims.
PremisecitationThe association between HPV infection and spontaneous abortions has rarely been investigated, with existing studies limited by small sample sizes and showing conflicting results.
“The association between HPV infection and spontaneous abortions has rarely been investigated in the literature to date, with existing studies being limited by small sample sizes and showing conflicting results [29, 30].”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [29] S. D. Popescu, A. G. Boiangiu, R. M. Sima, L. Bilteanu, S. Vladareanu, and R. Vladareanu, “ Maternal HPV Infection and the Estimated Risks for Adverse Pregnancy Outcomes—A Systematic Review,” Diagnostics 12, no. 6 (2022): 1471. 35741280 PMC9221727 source
The Results (§3.2.1, Miscarriage) say the published data are contradictory and limited by small sample size, supporting the claim about conflicting findings and study limitations. The review identifies nine studies investigating the link and says many studies have examined HPV as a possible miscarriage risk factor; it does not establish that the association has rarely been investigated. (LLM, conf=0.83)
Experimental — accuracy not yet measured - cites [30] A. Basonidis, A. Liberis, A. Daniilidis, S. Petousis, and K. Dinas, “ Human Papilloma Virus Infection and Miscarriage: Is There an Association?,” Taiwanese Journal of Obstetrics & Gynecology 59, no. 5 (2020): 656– 659. 32917313 source
The Abstract reports conflicting findings and says the studies are limited by small sample sizes and/or methodological limitations. The section on studies evaluating HPV infection and miscarriage likewise says most studies were small. The paper does not establish the stronger claim that the association has rarely been investigated. (LLM, conf=0.83)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationPregnancy rate was higher among patients treated by laser ablation than an untreated control group, and time to conception was not significantly associated with any ablative treatment.
“Pregnancy rate was higher among patients treated by laser ablation than an untreated control group, and time to conception was not significantly associated with any ablative treatment.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [12] M. Kyrgiou, A. Mitra, M. Arbyn, et al., “ Fertility and Early Pregnancy Outcomes After Treatment for Cervical Intraepithelial Neoplasia: Systematic Review and Meta‐Analysis,” BMJ 349 (2014): g6192. 25352501 PMC4212006 source
May combine two claims.
Findingown dataOf the 227 first postscreening pregnancies reported, 11 were voluntarily terminated, 49 ended in spontaneous abortion, 147 were delivered (livebirth or stillbirth), and 20 were ongoing at the time of data collection.
“Of the 227 first postscreening pregnancies reported, 11 were voluntarily terminated, 49 ended in spontaneous abortion, 147 were delivered (livebirth or stillbirth), and 20 were ongoing at the time of data collection (Table S2).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataA total of 760 participants (219 treated by thermal ablation and 541 untreated) completed the survey.
“A total of 760 participants (219 treated and 541 untreated) completed the survey, with a mean follow‐up time of 1297 days.”
- Also stated in: § Results · plain
“A total of 760 participants (219 treated by TA) completed the survey and were followed up for an average of 1297 days (range 244–2432).”
Quote in the paperNot a substantial claim- Also stated in: § Results · plain
May combine two claims.
Findingown dataDistribution of time to pregnancy varied according to HPV status and treatment group, with a peak of pregnancies observed after 1 year among untreated HPV-positive women.
“Distribution of time to pregnancy varied according to HPV status and treatment group (Figure S2), with a peak of pregnancies observed after 1 year among untreated HPV‐positive women, mirroring the recommendations given by healthcare providers to this group of participants to avoid pregnancy until their follow‐up visit.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThe mean follow-up time was 1297 days (range 244-2432).
“A total of 760 participants (219 treated by TA) completed the survey and were followed up for an average of 1297 days (range 244–2432).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenThe questionnaire was pretested on 10 participants and further adapted.
“The questionnaire was designed by a team of physicians specialised in gynaecology‐obstetrics and public health, and medical anthropologists, and was further adapted after being pretested on 10 participants.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Premisenone givenThe safety of thermal ablation for future fertility and pregnancy outcomes is still unclear.
“However, the safety of TA for future fertility and pregnancy outcomes is still unclear.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenIn both source studies, over 50% of women who underwent thermal ablation expressed a desire for future pregnancies.
“Notably, in both source studies, over 50% of women who underwent thermal ablation expressed a desire for future pregnancies.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Interpretationown dataThe peak of pregnancies after 1 year among untreated HPV-positive women mirrors the recommendations given by healthcare providers to this group to avoid pregnancy until their follow-up visit.
“Distribution of time to pregnancy varied according to HPV status and treatment group (Figure S2), with a peak of pregnancies observed after 1 year among untreated HPV‐positive women, mirroring the recommendations given by healthcare providers to this group of participants to avoid pregnancy until their follow‐up visit.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Study design and conductnone givenPotential confounders of the association between thermal ablation and miscarriage were identified a priori based on published literature and clinical experience.
“A priori potential confounders of the association between TA and miscarriage included age, tobacco consumption, BMI, suffering from a chronic disease, history of gynaecologic disease/surgery, history of miscarriage, HIV status, HPV status and presence of CIN2+ at time of initial screening.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThermal ablation with a heated metallic probe is recommended as an alternative to cryotherapy since 2019.
“Among available ablative therapies, thermal ablation (TA) with a heated metallic probe is recommended as an alternative to cryotherapy since 2019 [3].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] World Health Organization, “WHO Guidelines for the Use of Thermal Ablation for Cervical Pre‐Cancer Lesions,” 2019, https://www.who.int/publications‐detail‐redirect/guidelines‐use‐of‐thermal‐ablation‐for‐cervical‐pre‐cancer‐lesions. 31661202
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAs odds ratios are known to overestimate or underestimate the effect when the incidence of an outcome is common, adjusted ORs of more than 2.5 or less than 0.5 were corrected based on the formula proposed by Zhang et al.
“As odds ratios (OR) are known to overestimate (if OR > 1) or underestimate (if OR < 1) the effect when the incidence of an outcome is common, adjusted ORs of more than 2.5 or less than 0.5 were corrected based on the formula proposed by Zhang et al. [21]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [21] J. Zhang and K. F. Yu, “ What's the Relative Risk? A Method of Correcting the Odds Ratio in Cohort Studies of Common Outcomes,” Journal of the American Medical Association 280, no. 19 (1998): 1690– 1691. 9832001 source
May combine two claims.
Interpretationown dataThermal ablation did not significantly impact fertility nor miscarriage risk in the study population.
“In our study population, TA did not significantly impact fertility nor miscarriage risk.”
Quote in the paperSubstantial claim- Rests on an assumption: The adjusted analyses control for all relevant confounders, so the estimated associations between thermal ablation and pregnancy/miscarriage are not biased by unmeasured confounding.
- Rests on an assumption: Self-reported pregnancy and miscarriage data collected by phone interview are accurate and complete.
Classified as probably not a substantial claim. May combine two claims.
Study design and conductreasoningThe sample size was determined to obtain 80% power with 95% confidence for an estimated 10% difference in pregnancy rates between groups (30% control vs 20% thermal ablation) over an average of 3 years, giving a necessary control group of 441 participants and approximately 670 participants to be recruited.
“The size of the control group was calculated using Pearson's chi‐squared test to obtain 80% power with a 95% confidence level (95% CI) for an estimated 10% difference in pregnancy rates between both groups (30% in the control group vs. 20% in the TA group) over the full study period (estimated at an average of 3 years), giving a necessary sample size for the control group of 441 participants.”
- Also stated in: § Statistical Analyses · plain
“Considering a slightly lower participation rate of 70% in the control group, approximately 670 participants were considered necessary to be recruited.”
Quote in the paperSubstantial claim- Also stated in: § Statistical Analyses · plain
May combine two claims.
PremisecitationInternational screening guidelines recommend a screen-and-treat approach in resource-constrained settings, leading to a high proportion of women of reproductive age receiving treatment.
“The safety of cervical treatment is especially relevant in resource‐constrained settings where international screening guidelines recommend a ‘screen‐and‐treat approach’ to avoid loss to follow‐up, leading to a high proportion of women of reproductive age receiving treatment [7].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [7] World Health Organization, WHO Guideline for Screening and Treatment of Cervical Pre‐Cancer Lesions for Cervical Cancer Prevention, 2nd ed. (Geneva, Switzerland: WHO, 2021), https://www.who.int/publications‐detail‐redirect/9789240030824. 34314129
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S2 (checkable).
Interpretationown dataOur findings provide essential information on the safety of thermal ablation on subsequent fertility and pregnancy outcomes in a sub-Saharan African population.
“Our findings provide essential information on the safety of TA on subsequent fertility and pregnancy outcomes in a sub‐Saharan African population.”
Quote in the paperNot a substantial claim- Rests on an assumption: In low-resource contexts using a 'see and treat' approach, the risk of overtreatment is considerable.
- Rests on an assumption: Reassurance on the lack of negative impact of cervical treatment on future fertility improves screening coverage in a female target population of childbearing age.
- Rests on an assumption: Deleterious effects on fertility lead to major social and psychological impacts.
Probably not a substantial claim: may not pass S2 (checkable).
Interpretationown dataThe study fills an important evidence gap on the safety of thermal ablation for women's fertility and pregnancy outcomes.
“Although our study fills an important evidence gap on the safety of TA for women's fertility and pregnancy outcomes, several study limitations should be acknowledged.”
Quote in the paperNot a substantial claim- Rests on an assumption: In low-resource contexts using a 'see and treat' approach, the risk of overtreatment is considerable.
May combine two claims.
Study design and conductown dataThe study sample did not provide sufficient power to assess absolute differences in fertility of less than 10%, as well as less frequent pregnancy outcomes such as preterm birth, late miscarriages, premature membrane rupture, low birthweight or ectopic pregnancy.
“Finally, our study sample did not provide sufficient power to assess absolute differences in fertility of less than 10%, as well as less frequent pregnancy outcomes such as preterm birth, late miscarriages, premature membrane rupture, low birthweight or ectopic pregnancy, which have been associated with excisional cervical treatment [12, 22].”
Quote in the paperSubstantial claimMay combine two claims.
Premisenone givenPrevious literature on miscarriage after thermal ablation is scarce and has provided conflicting results.
“Previous literature published on the topic is scarce and has provided conflicting results.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationAn earlier cohort study of women treated by thermal ablation between 1975 and 1989 reported outcomes of 226 pregnancies without detecting an increase in miscarriage rates compared to expected figures, but did not include a control group.
“On the contrary, an earlier cohort study of women treated by TA between 1975 and 1989 reported the outcomes of 226 pregnancies without detecting an increase in miscarriage rates compared to expected figures [28]. However, the study did not include a control group.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [28] H. K. Gordon and I. D. Duncan, “ Effective Destruction of Cervical Intraepithelial Neoplasia (CIN) 3 at 100°C Using the Semm Cold Coagulator: 14 Years Experience,” BJOG: An International Journal of Obstetrics & Gynaecology 98, no. 1 (1991): 14– 20. 1998626 source
Classified as probably not a substantial claim.
Study design and conductnone givenThe study was not designed to assess the impact of HPV infection on pregnancy outcomes.
“Although this study was not designed to assess the impact of HPV infection on pregnancy outcomes, our results further indicate a strong association between HPV positivity and miscarriage rate.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationA study in the United Kingdom observed a higher overall rate of miscarriages in women treated by thermal ablation than in untreated women, but the analysis was not adjusted for potential confounders.
“Similar to our findings, a study led in the United Kingdom [27] observed a higher overall rate of miscarriages in women treated by TA than in untreated women, but the analysis was not adjusted for potential confounders.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [27] D. Papoutsis, M. Underwood, W. Parry‐Smith, and J. Panikkar, “ Early and Late Pregnancy Outcomes in Women Treated With Cold‐Coagulation Versus LLETZ Cervical Treatment for Cervical Intraepithelial Neoplasia; a Retrospective Cohort Study,” Archives of Gynecology and Obstetrics 297, no. 4 (2018): 1015– 1025. 29404740 source
May combine two claims.
Study design and conductown dataThe study had reliable data from previous clinical trials on cervical treatment received and HPV status, minimising the risk of misclassification.
“Strengths of this study include the availability of reliable data from previous clinical trials on cervical treatment received and HPV status, therefore minimising the risk of misclassification.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenPotential reporting bias due to stigma around infertility may have led to misclassification of self-reported desire for pregnancy.
“However, potential reporting bias due to stigma around infertility may have led to misclassification of self‐reported desire for pregnancy.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown dataThe study population varied considerably in duration of follow-up due to the 5-year screening period and censoring of a limited number of participants who received a different cervical treatment; these variations were accounted for in the survival analysis.
“The study population also varied considerably in the duration of follow‐up, due to the 5‐year screening period and censoring of a limited number of participants having received a different cervical treatment. These variations, however, were accounted for in the survival analysis.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
PremisecitationThermal ablation is one of the main recommended methods by the WHO for the treatment of cervical precancerous lesions, due to its accessibility, affordability and effectiveness.
“This is particularly relevant in low‐income contexts where TA is one of the main recommended methods by the WHO for the treatment of cervical precancerous lesions, due to its accessibility, affordability and effectiveness [3, 6].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [3] World Health Organization, “WHO Guidelines for the Use of Thermal Ablation for Cervical Pre‐Cancer Lesions,” 2019, https://www.who.int/publications‐detail‐redirect/guidelines‐use‐of‐thermal‐ablation‐for‐cervical‐pre‐cancer‐lesions. 31661202
Not checked in the free run.
- cites [6] C. Sauvaget, S. Bazikamwe, E. Lucas, A. Ndayikengurukiye, S. Harerimana, and P. Barango, “ Evaluation of Effectiveness, Acceptability and Safety of Thermal Ablation in the Treatment of Cervical Neoplasia in Burundi,” International Journal of Cancer 151, no. 7 (2022): 1120– 1126. 35567576 source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA study in the United States assessed the effect of laser vaporisation on pregnancy outcomes and found no significant effect on the rate of spontaneous abortions compared to a control group of untreated women.
“Another study conducted in the United States assessed the effect of laser vaporisation on pregnancy outcomes and found no significant effect on the rate of spontaneous abortions compared to a control group of untreated women [23].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [23] M. Spitzer, J. Herman, B. A. Krumholz, and M. Lesser, “ The Fertility of Women After Cervical Laser Surgery,” Obstetrics and Gynecology 86, no. 4 Pt 1 (1995): 504– 508. 7675369 source
May combine two claims.
Study design and conductreasoningA high participation rate of nearly 80% was achieved through a rigorous recall procedure, limiting the risk of selection bias.
“Further, a high participation rate of nearly 80% was achieved thanks to a rigorous recall procedure, limiting the risk of selection bias.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown dataThere were baseline differences between study groups, most notably roughly 50% higher prevalence of reported past infertility among women in the thermal ablation group; these disparities were included as potential confounders in the adjusted analysis.
“Third, there were some differences in baseline characteristics between the study groups, most notably the roughly 50% higher prevalence of reported past infertility among women in the thermal ablation group. These baseline disparities, however, were included as potential confounders in the adjusted analysis.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductreasoningThe study attempted to account for potential imbalance by adjusting for HPV status at the initial screening visit, although residual confounding cannot be excluded.
“We have attempted to account for this potential imbalance by adjusting for HPV status at the initial screening visit, although residual confounding cannot be excluded.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningNone of the published research has shown significantly reduced fertility following ablative treatment, which is consistent with our findings.
“Despite some differences across studies, which may be explained by heterogeneous study populations and adjustment for different variables, none of the published research has shown significantly reduced fertility following ablative treatment, which is consistent with our findings.”
Quote in the paperSubstantial claim
The paper relies on this without support.
The adjusted analyses control for all relevant confounders, so the estimated associations between thermal ablation and pregnancy/miscarriage are not biased by unmeasured confounding.
“Adjusted for potential confounders, the hazard ratio of pregnancy for treated compared with untreated women was 0.82 (0.54–1.24, p = 0.350).”
The paper relies on this without support.
Self-reported pregnancy and miscarriage data collected by phone interview are accurate and complete.
“Data collection took place between October 2021 and March 2022, during which women from both original screening trials were invited to answer a phone survey (Figure 1).”
“Interviews were led by two Cameroonian medical anthropologists trained in CC screening and a Cameroonian physician, based on a paper questionnaire structured along the following sections: (i) update of CC screening and treatment, (ii) medical history and risk factors, (iii) obstetrical history since CC screening and (iv) obstetrical history prior to screening.”
The paper relies on this without support.
The findings from this Cameroonian cohort are generalizable to other low-income settings, supporting widespread use of thermal ablation.
“Our results support the widespread use of TA as a treatment of choice for precancerous cervical lesions in low‐income settings.”
The paper relies on this without support.
The adjusted model including thermal ablation, age, HPV status, HIV status, BMI category, and tobacco consumption adequately controls for confounding of the association between thermal ablation and miscarriage.
“OR adjusted for thermal ablation, age, HPV status, HIV status, BMI category and tobacco consumption.”
The paper relies on this without support.
In low-resource contexts using a 'see and treat' approach, the risk of overtreatment is considerable.
“Safety of TA is especially important in low‐resource contexts using a ‘see and treat’ approach where the risk of overtreatment is considerable.”
The paper relies on this without support.
Reassurance on the lack of negative impact of cervical treatment on future fertility improves screening coverage in a female target population of childbearing age.
“Reassurance on the lack of negative impact of cervical treatment on future fertility is paramount to improve screening coverage in a female target population of childbearing age, as deleterious effects on fertility may lead to major social and psychological impacts.”
The paper relies on this without support.
Deleterious effects on fertility lead to major social and psychological impacts.
“Reassurance on the lack of negative impact of cervical treatment on future fertility is paramount to improve screening coverage in a female target population of childbearing age, as deleterious effects on fertility may lead to major social and psychological impacts.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Person-years differ between exhaustive groupings
MinorIn Table 2, the three age groups total 2,134 person-years, while the treated and untreated groups total 2,127. Both groupings describe the same cohort, and rounding the individual person-year values cannot account for a seven-year difference.
“| <35 | 147 (58.8) | 484 | 30.3 (25.8–35.7) | | | | | | 35–40 | 64 (23.5) | 807 | 7.9 (6.2–10.1) | 0.81 (0.78–0.84) | <0.001 | 0.82 (0.79–0.85) | <0.001 | | >40 | 16 (6.6) | 843 | 1.9 (1.2–3.1) | | | | |”
“| No | 165 (30.5) | 1509 | 10.9 (9.4–12.7) | Ref | | Ref | | | Yes | 62 (28.3) | 618 | 10.0 (7.8–12.9) | 0.91 (0.68–1.22) | 0.547 | 0.82 (0.54–1.24) | 0.350 |”
Past-miscarriage percentages exceed 100%
MinorThe two categories in Table 1 are exhaustive, but their reported percentages sum to 100.9%. The 133 women without a past miscarriage are 61.3% of the 217 women with a recorded answer, not 62.2%.
“| Yes | 84 (38.7) | 202 (37.4) | |”
“| No | 133 (62.2) | 338 (62.6) | |”
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699 · see citing works
Zhang, J., & Yu, K. F. (1998) · JAMA · doi:10.1001/jama.280.19.1690 · Cited by 4,138 · see citing works
Bruni, L., Díaz, M., Barrionuevo-Rosas, L., Herrero, R., Bray, F., Bosch, F. X., de Sanjosé, S., & Castellsagué, X. (2016) · The Lancet Global Health · doi:10.1016/s2214-109x(16)30099-7 · Cited by 827 · see citing works
Management of women who test positive for high-risk types of human papillomavirus: the HART study
Cuzick, J., Szarewski, A., Cubie, H., Hulman, G., Kitchener, H., Luesley, D., McGoogan, E., Menon, U., Terry, G., Edwards, R., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14955-0 · Cited by 510 · see citing works
(2024) · doi:10.2471/b09020 · Cited by 243 · see citing works
Kyrgiou, M., Mitra, A., Arbyn, M., Stasinou, S. M., Martin-Hirsch, P., Bennett, P., & Paraskevaidis, E. (2014) · BMJ · doi:10.1136/bmj.g6192 · Cited by 188 · see citing works
Pinder, L. F., Parham, G. P., Basu, P. S., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30635-7 · Cited by 89 · see citing works
Randall, T. C., Sauvaget, C., Muwonge, R., Trimble, E. L., & Jeronimo, J. (2019) · Preventive Medicine · doi:10.1016/j.ypmed.2018.10.006 · Cited by 88 · see citing works
Kunckler, M., Schumacher, F., Kenfack, B., Catarino, R., Viviano, M., Tincho, E., Tebeu, P. M., Temogne, L., Vassilakos, P., & Petignat, P. (2017) · Cancer Medicine · doi:10.1002/cam4.1089 · Cited by 77 · see citing works
Self-citationEnvironmental and Psychosocial Barriers to and Benefits of Cervical Cancer Screening in Kenya
Buchanan Lunsford, N., Ragan, K., Lee Smith, J., Saraiya, M., & Aketch, M. (2017) · The Oncologist · doi:10.1634/theoncologist.2016-0213 · Cited by 74 · see citing works
GORDON, H. K., & DUNCAN, I. D. (1991) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1991.tb10304.x · Cited by 67 · see citing works
Spracklen, C., Harland, K., Stegmann, B., & Saftlas, A. (2013) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.12209 · Cited by 52 · see citing works
Effects of cervical conisation on pregnancy outcome: a meta-analysis
Zhuang, H., Hong, S., Zheng, L., Zhang, L., Zhuang, X., Wei, H., & Yang, Y. (2019) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2018.1463206 · Cited by 51 · see citing works
Does treatment for cervical intraepithelial neoplasia affect fertility and pregnancy?
Hammond, R. H., & Edmonds, D. K. (1990) · BMJ · doi:10.1136/bmj.301.6765.1344 · Cited by 40 · see citing works
The Fertility of Women After Cervical Laser Surgery
SPITZER, M. (1995) · Obstetrics & Gynecology · doi:10.1016/0029-7844(95)00237-l · Cited by 33 · see citing works
Levy, J., de Preux, M., Kenfack, B., et al. (2020) · Cancer Medicine · doi:10.1002/cam4.3355 · Cited by 33 · see citing works
Self-citationPetignat, P., Kenfack, B., Wisniak, A., Saïji, E., Tille, J., Fouogue, J. T., Catarino, R., Tincho, E., & Vassilakos, P. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-052504 · Cited by 22 · see citing works
Self-citationKalliala, I., Anttila, A., Dyba, T., Hakulinen, T., Halttunen, M., & Nieminen, P. (2012) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2011.03042.x · Cited by 19 · see citing works
Papoutsis, D., Underwood, M., Parry-Smith, W., & Panikkar, J. (2018) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-018-4704-x · Cited by 17 · see citing works
Maternal HPV Infection and the Estimated Risks for Adverse Pregnancy Outcomes—A Systematic Review
Popescu, S. D., Boiangiu, A. G., Sima, R.-M., Bilteanu, L., Vladareanu, S., & Vladareanu, R. (2022) · Diagnostics · doi:10.3390/diagnostics12061471 · Cited by 17 · see citing works
Broquet, C., Vassilakos, P., Ndam Nsangou, F. M., Kenfack, B., Noubom, M., Tincho, E., Jeannot, E., Wisniak, A., & Petignat, P. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-057234 · Cited by 17 · see citing works
Self-citationNon‐uptake of colposcopy in a resource‐poor setting
Chigbu, C. O., & Aniebue, U. U. (2011) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2010.11.017 · Cited by 16 · see citing works
Pregnancy after Treatment for Cervical Cancer Precursor Lesions in a Retrospective Matched Cohort
Naleway, A. L., Weinmann, S., Krishnarajah, G., Arondekar, B., Fernandez, J., Swamy, G., & Myers, E. (2015) · PLOS ONE · doi:10.1371/journal.pone.0117525 · Cited by 14 · see citing works
A prospective study of treatments for cervical intraepithelial neoplasia and fecundability
Wise, L. A., Willis, S. K., Perkins, R. B., Wesselink, A. K., Klann, A., Crowe, H. M., Hahn, K. A., Mikkelsen, E. M., & Hatch, E. E. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.12.017 · Cited by 14 · see citing works
Human papilloma virus infection and miscarriage: is there an association?
Basonidis, A., Liberis, A., Daniilidis, A., Petousis, S., & Dinas, K. (2020) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2020.07.005 · Cited by 12 · see citing works
de Fouw, M., Oosting, R. M., Eijkel, B. I. M., et al. (2020) · Health and Technology · doi:10.1007/s12553-020-00459-w · Cited by 6 · see citing works
Sauvaget, C., Bazikamwe, S., Lucas, E., Ndayikengurukiye, A., Harerimana, S., & Barango, P. (2022) · International Journal of Cancer · doi:10.1002/ijc.34117 · Cited by 5 · see citing works
Flagged first, then by citations
Research works printed but not linked: 3
- World Health Organization, 2020, Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem
- World Health Organization, 2021, WHO Guideline for Screening and Treatment of Cervical Pre‐Cancer Lesions for Cervical Cancer Prevention
- 2011, WHO Guidelines: Use of Cryotherapy for Cervical Intraepithelial Neoplasia
Cited by
Sorted by citations
Hồ, Q. N., Le, Q. T., Pham, A. H. T., et al. (2025) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.70623 · Cited by 3 · see citing works
LINC01094 targets miR-1266-5p to halt neoplasm progression of cervical cancer
Zhang, W., Shang, W., Cao, J., et al. (2025) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2025.2522866 · Cited by 1 · see citing works
Chen, R., Wang, C., & Li, B. (2025) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.18144
Sun, F., Qi, Y., Zhuang, L., et al. (2026) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2026.02.010
- Authors
- Wisniak, A., Yakam, V., Bolo, S. E., Moukam, A., Sormani, J., Vassilakos, P., Kenfack, B., & Petignat, P.
- Affiliations
- University of Geneva (CH)
- Department of Gynecology and Obstetrics Dschang Regional Hospital Annex Dschang Cameroon
- Institute of Global Health, Faculty of Medicine University of Geneva Geneva Switzerland
- HES-SO Genève (CH)
- University Hospital of Geneva (CH)
- Université de Dschang (CM)
- Corresponding author
- Wisniak, Ania
- ORCID
- Venue
- BJOG: An International Journal of Obstetrics & Gynaecology
- Publisher
- Wiley
- Published
- 2024-09-16
- Volume
- 132
- Issue
- 2
- Pages
- 167-177
- ISSN
- 0306-5456 (ISSN-L)
- 1470-0328
- 1471-0528
- PMC
- PMC11625656
- OpenAlex
- W4402555062
- Semantic Scholar
- f039c6d68647f56299cba3ef00b91356b534ace3
- Cited by
- 4
- References
- 27
- Citations by year
- 2026: 1 · 2025: 3
- FWCI
- 1.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- BJOG An International Journal of Obstetrics & Gynaecology (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion, cc-by-nc)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by-nc-nd)
- ArODES (HES-SO (https://www.hes-so.ch/)) (submittedVersion)
- Funders
- Fondation pour la Recherche Nuovo-Soldati
- Hôpitaux Universitaires de Genève
- Topics
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Keywords
- cervical intraepithelial neoplasia, thermal ablation, fertility, miscarriage, pregnancy outcomes, cervical cancer screening, human papillomavirus, low-income settings, Cameroon
- MeSH terms
- Abortion, Spontaneous, Adult, Cameroon, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Female, Fertility, Humans, Middle Aged, Pregnancy, Pregnancy Outcome, Retrospective Studies, Cohort Studies, Incidence, Ablation Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-16.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-16.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review